The Global Burden of Alcohol-associated Cirrhosis and Cancer in Young and Middle-aged Adults
Pojsakorn Danpanichkul(Texas Tech University), Brian P. Lee(University of Southern California), Daniel Q. Huang(National University of Singapore), Darren Jun Hao Tan(National University Hospital), Zhen Yu Wong(Nottingham University Hospitals NHS Trust), Wen Hui Lim(National University of Singapore), Mazen Noureddin(Methodist Hospital), Tomoya Sano, Vincent Chen(University of Michigan), Mark Muthiah(National University of Singapore), Benjamin Nah, Apichat Kaewdech(Prince of Songkla University), Cheng Han Ng(Kurume University), Vijay Ramadoss, Jia Hong Koh(National University Hospital), Hirokazu Takahashi, Ken Liu, Elizabeth Thong, Karn Wijarnpreecha(University of Arizona), Margaret Teng(National University of Singapore), Kwanjit Duangsonk(Chiang Mai University)
Cited by 34
Related Papers
The global burden of metabolic disease: Data from 2000 to 2019
|Cell Metabolism|2023|777
Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals
|The Journal of Clinical Endocrinology & Metabolism|2022|306
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)
|Hepatology International|2020|295
Genome-wide association study of serum liver enzymes implicates diverse metabolic and liver pathology
|Nature Communications|2021|130
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
|Clinical Gastroenterology and Hepatology|2023|126